INDOCOPharmaceuticals
Indoco Remedies Ltd — Balance Sheet
₹164.00
-6.69%
Indoco Remedies Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Treasury Shares Number | 86600.00 | 31850.00 | — | — | — |
| Ordinary Shares Number | 9.22 Cr | 9.22 Cr | 9.22 Cr | 9.22 Cr | — |
| Share Issued | 9.22 Cr | 9.22 Cr | 9.22 Cr | 9.22 Cr | — |
| Net Debt | 965.93 Cr | 640.29 Cr | 303.58 Cr | 226.74 Cr | — |
| Total Debt | 993.56 Cr | 671.95 Cr | 332.85 Cr | 256.67 Cr | — |
| Tangible Book Value | 829.76 Cr | 921.88 Cr | 903.98 Cr | 812.67 Cr | — |
| Invested Capital | 2.00K Cr | 1.77K Cr | 1.34K Cr | 1.15K Cr | — |
| Working Capital | 193.35 Cr | 342.34 Cr | 389.06 Cr | 348.77 Cr | — |
| Net Tangible Assets | 829.76 Cr | 921.88 Cr | 903.98 Cr | 812.67 Cr | — |
| Capital Lease Obligations | 15.53 Cr | 16.80 Cr | 18.35 Cr | 12.46 Cr | — |
| Common Stock Equity | 1.02K Cr | 1.11K Cr | 1.03K Cr | 904.64 Cr | — |
| Total Capitalization | 1.56K Cr | 1.46K Cr | 1.17K Cr | 1.00K Cr | — |
| Total Equity Gross Minority Interest | 1.02K Cr | 1.11K Cr | 1.03K Cr | 904.64 Cr | — |
| Minority Interest | -3.62 Cr | 0.60 Cr | 0.00 | — | — |
| Stockholders Equity | 1.02K Cr | 1.11K Cr | 1.03K Cr | 904.64 Cr | — |
| Other Equity Interest | 1.00K Cr | 3.54 Cr | 0.66 Cr | 886.21 Cr | — |
| Taxes Receivable | 18.41 Cr | 1.76 Cr | 5.40 Cr | — | — |
| Accounts Receivable | 352.41 Cr | 406.20 Cr | 350.94 Cr | 297.25 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 20.41 Cr | 25.59 Cr | 14.92 Cr | 41.62 Cr | — |
| Other Short Term Investments | 8.31 Cr | 10.74 Cr | 3.99 Cr | 24.15 Cr | — |
| Cash And Cash Equivalents | 12.10 Cr | 14.86 Cr | 10.92 Cr | 17.47 Cr | — |
| Capital Stock | 18.45 Cr | 18.44 Cr | 18.43 Cr | 18.43 Cr | — |
| Common Stock | 18.45 Cr | 18.44 Cr | 18.43 Cr | 18.43 Cr | — |
| Total Liabilities Net Minority Interest | 1.41K Cr | 1.03K Cr | 629.95 Cr | 581.45 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 603.54 Cr | 421.90 Cr | 205.44 Cr | 156.60 Cr | — |
| Other Non Current Liabilities | 7.41 Cr | 7.36 Cr | 7.36 Cr | 7.41 Cr | — |
| Non Current Deferred Taxes Liabilities | 13.36 Cr | 11.83 Cr | 6.14 Cr | 10.60 Cr | — |
| Long Term Debt And Capital Lease Obligation | 542.56 Cr | 364.13 Cr | 158.54 Cr | 106.85 Cr | — |
| Long Term Capital Lease Obligation | 9.36 Cr | 12.41 Cr | 15.04 Cr | 10.96 Cr | — |
| Long Term Debt | 533.20 Cr | 351.73 Cr | 143.50 Cr | 95.88 Cr | — |
| Long Term Provisions | 35.82 Cr | 33.68 Cr | 33.40 Cr | 31.74 Cr | — |
| Current Liabilities | 807.99 Cr | 612.33 Cr | 424.51 Cr | 424.85 Cr | — |
| Other Current Liabilities | 23.16 Cr | 0.95 Cr | 57.29 Cr | 85.69 Cr | — |
| Current Debt And Capital Lease Obligation | 451.00 Cr | 307.82 Cr | 174.31 Cr | 149.82 Cr | — |
| Current Capital Lease Obligation | 6.17 Cr | 4.40 Cr | 3.31 Cr | 1.50 Cr | — |
| Current Debt | 444.83 Cr | 303.42 Cr | 171.00 Cr | 148.32 Cr | — |
| Current Provisions | 45.15 Cr | 48.36 Cr | 49.54 Cr | 47.45 Cr | — |
| Payables | 208.13 Cr | 201.73 Cr | 159.79 Cr | 138.18 Cr | — |
| Accounts Payable | 208.13 Cr | 153.64 Cr | 123.46 Cr | 133.29 Cr | — |
| Total Assets | 2.43K Cr | 2.14K Cr | 1.66K Cr | 1.49K Cr | — |
| Total Non Current Assets | 1.43K Cr | 1.19K Cr | 844.63 Cr | 712.47 Cr | — |
| Other Non Current Assets | 99.84 Cr | 99.66 Cr | 46.50 Cr | 32.57 Cr | — |
| Investmentin Financial Assets | 7.70 Cr | 6.62 Cr | 1.47 Cr | 1.86 Cr | — |
| Available For Sale Securities | 7.70 Cr | 6.62 Cr | 1.47 Cr | 1.86 Cr | — |
| Goodwill And Other Intangible Assets | 192.24 Cr | 188.02 Cr | 124.27 Cr | 91.97 Cr | — |
| Other Intangible Assets | 170.72 Cr | 166.49 Cr | 124.18 Cr | 91.88 Cr | — |
| Goodwill | 21.52 Cr | 21.52 Cr | 0.09 Cr | 0.09 Cr | — |
| Net PPE | 1.13K Cr | 979.28 Cr | 706.30 Cr | 604.38 Cr | — |
| Gross PPE | 1.13K Cr | 1.53K Cr | 1.21K Cr | 1.06K Cr | — |
| Construction In Progress | 276.12 Cr | 191.07 Cr | 94.11 Cr | 72.53 Cr | — |
| Other Properties | 849.06 Cr | 322.08 Cr | 286.97 Cr | 254.11 Cr | — |
| Current Assets | 1.00K Cr | 954.67 Cr | 813.57 Cr | 773.62 Cr | — |
| Other Current Assets | 187.45 Cr | 153.63 Cr | 113.22 Cr | 121.39 Cr | — |
| Inventory | 419.35 Cr | 353.06 Cr | 325.99 Cr | 310.52 Cr | — |
| Other Receivables | 3.31 Cr | 19.88 Cr | 6.31 Cr | 1.44 Cr | — |
| Retained Earnings | — | 764.54 Cr | 686.78 Cr | 563.82 Cr | 428.17 Cr |
| Allowance For Doubtful Accounts Receivable | — | -32.03 Cr | -31.88 Cr | -16.34 Cr | -2.60 Cr |
| Gross Accounts Receivable | — | 438.24 Cr | 382.83 Cr | 313.58 Cr | 236.43 Cr |
| Cash Financial | — | 14.86 Cr | 10.92 Cr | 16.77 Cr | 8.79 Cr |
| Additional Paid In Capital | — | 64.98 Cr | 64.21 Cr | 64.21 Cr | 64.21 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 33.68 Cr | 33.40 Cr | 31.74 Cr | 27.77 Cr |
| Other Payable | — | 47.76 Cr | 36.04 Cr | 3.84 Cr | 4.57 Cr |
| Dividends Payable | — | 0.32 Cr | 0.29 Cr | 0.28 Cr | 0.25 Cr |
| Non Current Prepaid Assets | — | 9.27 Cr | 5.45 Cr | 5.15 Cr | 4.42 Cr |
| Accumulated Depreciation | — | -553.31 Cr | -501.01 Cr | -451.66 Cr | -406.56 Cr |
| Machinery Furniture Equipment | — | 622.43 Cr | 515.75 Cr | 452.40 Cr | 426.48 Cr |
| Buildings And Improvements | — | 325.12 Cr | 257.35 Cr | 240.56 Cr | 230.43 Cr |
| Land And Improvements | — | 71.89 Cr | 53.13 Cr | 36.44 Cr | 36.44 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 9.47 Cr | 2.41 Cr | 2.31 Cr | 4.92 Cr |
| Prepaid Assets | — | 138.70 Cr | 107.60 Cr | 120.50 Cr | 132.85 Cr |
| Finished Goods | — | 78.68 Cr | 55.99 Cr | 77.13 Cr | 54.48 Cr |
| Work In Process | — | 83.80 Cr | 57.29 Cr | 42.71 Cr | 39.05 Cr |
| Raw Materials | — | 190.58 Cr | 212.70 Cr | 190.68 Cr | 144.32 Cr |
| Cash Equivalents | — | — | 0.73 Cr | 0.69 Cr | 0.63 Cr |
| Total Tax Payable | — | — | 0.00 | 0.78 Cr | 0.00 |
| Long Term Equity Investment | — | — | 1.46 Cr | 0.02 Cr | 0.02 Cr |
| Investments In Other Ventures Under Equity Method | — | — | 1.46 Cr | 0.02 Cr | 0.02 Cr |
| Non Current Deferred Taxes Assets | — | — | — | 0.00 | 19.36 Cr |
| Other Inventories | — | — | — | — | 10.06 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Indoco Remedies Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.